Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects

NCT00255138 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Cancer
Cognitive Late Effects

Interventions

DRUG: Atomoxetine

Sponsor

Temple University

Collaborators

[object Object]